jak inhibitors from selleck
DESCRIPTION
jak inhibitors, jak2 inhibitor, jak1 inhibitor, jak3 inhibitorTRANSCRIPT
Inhibitors of JAK/STAT Pathway
file:///E|/work/e-marketing/newsletter/2011.10.30_Product-JAK-STAT-Inhibitor/Product-JAK-STAT-Inhibitor.html[2012/2/8 17:55:08]
Unable to read? View web version.
| Inhibitor | Antibody | siRNA | Peptide |Free Sample
ProgramScientificReviews
Coupons CatalogDownload
Dear customer,
Based on your research area, Selleck has special recommendations for you on our inhibitors of JAK /STAT pathway currently targeting JAK.
Cat. No. Inhibitor Name Purity
S2162 AZD1480 >99%
Bioactivity: AZD1480 is a novel potent small JAK2 inhibitor with an IC50 of0.26 nM.
S2179 LY2784544 >99%
Bioactivity: LY2784544 is a small molecule selective mutant JAK2 kinaseinhibitor with an IC50 of 68 nM.
S2686 NVP-BSK805 >99%
Bioactivity: NVP-BSK805 is a potent and selective quinoxaline JAK2inhibitor with IC50 of 0.48, 0.56 and 0.58 nM for JAK2 JH1, FL JAK V617Fand FL JAK2 wt, respectively.
Applications & Feedbacks
AZD1480 <More> LY2784544 <More>
Papers Using Selleck Inhibitors
AZD1480
Deshpande A, et al. Kinase domain mutations confer resistance to novelinhibitors targeting JAK2V617F in myeloproliferative neoplasms. Leukemia.2011 Sep 16. doi: 10.1038/leu.2011.255.
More Inhibitors TargetingJAK
AG-490 AT9283
AZ 960CP-690550(Tasocitinib)
Cyt387INCB018424(Ruxolitinib)
TG101209
More Inhibitors of the JAK/ STAT Pathway
by Target
STAT
More Inhibitors of SelleckSignal Pathways
by Pathway
Apoptosis
Cell Cycle / Checkpoint
Ion Channel
TGF-beta / Smad
by Research Area
Cancer
Immunology
Inflammation
Metabolic Disease
Follow us:
Tel: +1-713-922-4115Fax: +1-713-796-9816Email: [email protected] Address: 2626 South Loop West, Suite 225,Houston, TX 77054 USA.
Tel: +49-89-829693-77Fax: +49-89-829693-78Email: [email protected]: Karl-Schmid-Str. 14 81829 Munich,Germany.